{
  "drug_name": "Nonpregnant_vaginal_bleeding",
  "url": "https://wikem.org/wiki/Nonpregnant_vaginal_bleeding",
  "scraped_at": "2026-01-10T07:58:31.442515",
  "sections": {
    "Intro": {
      "text": "This page is for women of reproductive age. For younger patients, see\nprepubertal vaginal bleeding\n.\n",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Background": {
      "text": "This page is for the generalized approach to undifferentiated vaginal bleeding in non-pregnant women\nNormal menstruation:\n28 +/- 7 day cycles\n3-7 days of bleeding\nUsual amount bleeding per period 10-35 cc\nEach normal sized tampon or pad holds 5 cc when soaked through\nBleeding from the uterine corpus that is irregular in volume, frequency or duration, in absence of pregnancy, is abnormal\nVaginal bleeding before the age of menarche may be the result of infection, trauma (ex. sexual assault, foreign body) or a structural lesion",
      "subsections": {
        "Vaginal_bleeding_definitions": {
          "text": "Menorrhagia: >7 day (prolonged) or >80 mL/day (excessive) uterine bleeding at regular intervals\nMetrorrhagia: irregular vaginal bleeding outside the normal cycle\nMenometrorrhagia: excessive irregular vaginal bleeding\nIntermenstrual bleeding: variable amounts between regular menstrual periods\nMidcycle spotting: spotting just before ovulation (due to decline in estrogen)\nPolymenorrhea: frequent and light bleeding\nPostcoital bleeding: vaginal bleeding after intercourse, suggesting cervical pathology\nPostmenopausal bleeding: recurrence of bleeding >6 mo after menopause\nAmenorrhea: bleeding that is absent for > 6 months",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Vaginal_bleeding_definitions": {
      "text": "Menorrhagia: >7 day (prolonged) or >80 mL/day (excessive) uterine bleeding at regular intervals\nMetrorrhagia: irregular vaginal bleeding outside the normal cycle\nMenometrorrhagia: excessive irregular vaginal bleeding\nIntermenstrual bleeding: variable amounts between regular menstrual periods\nMidcycle spotting: spotting just before ovulation (due to decline in estrogen)\nPolymenorrhea: frequent and light bleeding\nPostcoital bleeding: vaginal bleeding after intercourse, suggesting cervical pathology\nPostmenopausal bleeding: recurrence of bleeding >6 mo after menopause\nAmenorrhea: bleeding that is absent for > 6 months",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Clinical_Features": {
      "text": "Vaginal bleeding in a non-pregnant woman",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Differential_Diagnosis": {
      "text": "",
      "subsections": {
        "Nonpregnant_Vaginal_Bleeding": {
          "text": "Systemic Causes\nCirrhosis\nCoagulopathy\n(\nVon Willebrand disease\n,\nITP\n)\nGroup A strep\nvaginitis (prepubertal girls)\nHormone replacement therapy\nAnticoagulants\nSelective Serotonin Reuptake Inhibitors (SSRIs)\nHypothyroidism\nPolycystic Ovary Syndrome\nSecondary anovulation\nReproductive Tract Causes\nAdenomyosis\nAtrophic endometrium\nDysfunctional uterine bleeding\nEndometriosis\nLeiomyoma\n(Fibroid)\nForeign Body\nInfection (\nvaginitis\n,\nPID\n)\nIUD\nNeoplasia (especially in women >45 years old or in younger women with other risk factors)\nVaginal Trauma",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Cirrhosis",
          "url": "https://wikem.org/wiki/Cirrhosis"
        },
        {
          "text": "Coagulopathy",
          "url": "https://wikem.org/wiki/Coagulopathy"
        },
        {
          "text": "Von Willebrand disease",
          "url": "https://wikem.org/wiki/Von_Willebrand_disease"
        },
        {
          "text": "ITP",
          "url": "https://wikem.org/wiki/ITP"
        },
        {
          "text": "Group A strep",
          "url": "https://wikem.org/wiki/Group_A_strep"
        },
        {
          "text": "Hypothyroidism",
          "url": "https://wikem.org/wiki/Hypothyroidism"
        },
        {
          "text": "Adenomyosis",
          "url": "https://wikem.org/wiki/Adenomyosis"
        },
        {
          "text": "Dysfunctional uterine bleeding",
          "url": "https://wikem.org/wiki/Dysfunctional_uterine_bleeding"
        },
        {
          "text": "Endometriosis",
          "url": "https://wikem.org/wiki/Endometriosis"
        },
        {
          "text": "Leiomyoma",
          "url": "https://wikem.org/wiki/Leiomyoma"
        },
        {
          "text": "Foreign Body",
          "url": "https://wikem.org/wiki/Foreign_Body"
        },
        {
          "text": "vaginitis",
          "url": "https://wikem.org/wiki/Vaginitis"
        },
        {
          "text": "PID",
          "url": "https://wikem.org/wiki/PID"
        },
        {
          "text": "Vaginal Trauma",
          "url": "https://wikem.org/wiki/Vaginal_Trauma"
        }
      ]
    },
    "Nonpregnant_Vaginal_Bleeding": {
      "text": "Systemic Causes\nCirrhosis\nCoagulopathy\n(\nVon Willebrand disease\n,\nITP\n)\nGroup A strep\nvaginitis (prepubertal girls)\nHormone replacement therapy\nAnticoagulants\nSelective Serotonin Reuptake Inhibitors (SSRIs)\nHypothyroidism\nPolycystic Ovary Syndrome\nSecondary anovulation\nReproductive Tract Causes\nAdenomyosis\nAtrophic endometrium\nDysfunctional uterine bleeding\nEndometriosis\nLeiomyoma\n(Fibroid)\nForeign Body\nInfection (\nvaginitis\n,\nPID\n)\nIUD\nNeoplasia (especially in women >45 years old or in younger women with other risk factors)\nVaginal Trauma",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Cirrhosis",
          "url": "https://wikem.org/wiki/Cirrhosis"
        },
        {
          "text": "Coagulopathy",
          "url": "https://wikem.org/wiki/Coagulopathy"
        },
        {
          "text": "Von Willebrand disease",
          "url": "https://wikem.org/wiki/Von_Willebrand_disease"
        },
        {
          "text": "ITP",
          "url": "https://wikem.org/wiki/ITP"
        },
        {
          "text": "Group A strep",
          "url": "https://wikem.org/wiki/Group_A_strep"
        },
        {
          "text": "Hypothyroidism",
          "url": "https://wikem.org/wiki/Hypothyroidism"
        },
        {
          "text": "Adenomyosis",
          "url": "https://wikem.org/wiki/Adenomyosis"
        },
        {
          "text": "Dysfunctional uterine bleeding",
          "url": "https://wikem.org/wiki/Dysfunctional_uterine_bleeding"
        },
        {
          "text": "Endometriosis",
          "url": "https://wikem.org/wiki/Endometriosis"
        },
        {
          "text": "Leiomyoma",
          "url": "https://wikem.org/wiki/Leiomyoma"
        },
        {
          "text": "Foreign Body",
          "url": "https://wikem.org/wiki/Foreign_Body"
        },
        {
          "text": "vaginitis",
          "url": "https://wikem.org/wiki/Vaginitis"
        },
        {
          "text": "PID",
          "url": "https://wikem.org/wiki/PID"
        },
        {
          "text": "Vaginal Trauma",
          "url": "https://wikem.org/wiki/Vaginal_Trauma"
        }
      ]
    },
    "Evaluation": {
      "text": "",
      "subsections": {
        "Work-Up": {
          "text": "Urine pregnancy\nComplete blood count\nCoags\n(if history of or suspect coagulopathy)\nTSH\n, prolactin (if suspect endocrine disorder)\nC. trachomatis\nand\nN. gonorrhoeae\ntesting if risk of infection (consider with post-coital bleeding)\nConsider follow up for non-emergent\npelvic ultrasound\nNo indication for emergent ultrasound in ED",
          "tables": []
        },
        "PALM-COEIN_Classification_of_Vaginal_Bleeding": {
          "text": "PALM\n: structural causes\nP\nolyp (AUB-P)\nA\ndenomyosis (AUB-A)\nL\neiomyoma (AUB-L)\nM\nalignancy and hyperplasia (AUB-M)\nCOEIN\n: nonstructural causes\nC\noagulopathy\n(AUB-C)\nO\nvulatory dysfunction (AUB-O)\nE\nndometrial (AUB-E)\nI\natrogenic (AUB-I)\nN\not yet classified (AUB-N)",
          "tables": []
        },
        "Diagnosis": {
          "text": "Common etiologies by age:\nAge 12-18: most commonly immature hypothalamic-pituitary-ovarian axis, also consider bleeding dyscrasia\nAge 19-39: most commonly structural lesion (fibroid, polyp) or PCOS\nAge 40+: most commonly endometrial atrophy, also consider malignancy especially in post-menopausal\n[2]\nHemodynamically stable patient in ED must rule-out:\nPregnancy\nTrauma\nBleeding dyscrasia\nInfection\nRetained\nvaginal foreign body\nIf work up negative, can refer for further outpatient work up",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Coags",
          "url": "https://wikem.org/wiki/Coags"
        },
        {
          "text": "TSH",
          "url": "https://wikem.org/wiki/TSH"
        },
        {
          "text": "C. trachomatis",
          "url": "https://wikem.org/wiki/C._trachomatis"
        },
        {
          "text": "N. gonorrhoeae",
          "url": "https://wikem.org/wiki/N._gonorrhoeae"
        },
        {
          "text": "pelvic ultrasound",
          "url": "https://wikem.org/wiki/Pelvic_ultrasound"
        },
        {
          "text": "Coagulopathy",
          "url": "https://wikem.org/wiki/Coagulopathy"
        },
        {
          "text": "Pregnancy",
          "url": "https://wikem.org/wiki/Pregnancy"
        },
        {
          "text": "Trauma",
          "url": "https://wikem.org/wiki/Trauma"
        },
        {
          "text": "Bleeding dyscrasia",
          "url": "https://wikem.org/wiki/Coagulopathy"
        },
        {
          "text": "Infection",
          "url": "https://wikem.org/wiki/Infection"
        },
        {
          "text": "vaginal foreign body",
          "url": "https://wikem.org/wiki/Vaginal_foreign_body"
        }
      ]
    },
    "Work-Up": {
      "text": "Urine pregnancy\nComplete blood count\nCoags\n(if history of or suspect coagulopathy)\nTSH\n, prolactin (if suspect endocrine disorder)\nC. trachomatis\nand\nN. gonorrhoeae\ntesting if risk of infection (consider with post-coital bleeding)\nConsider follow up for non-emergent\npelvic ultrasound\nNo indication for emergent ultrasound in ED",
      "subsections": {
        "PALM-COEIN_Classification_of_Vaginal_Bleeding": {
          "text": "PALM\n: structural causes\nP\nolyp (AUB-P)\nA\ndenomyosis (AUB-A)\nL\neiomyoma (AUB-L)\nM\nalignancy and hyperplasia (AUB-M)\nCOEIN\n: nonstructural causes\nC\noagulopathy\n(AUB-C)\nO\nvulatory dysfunction (AUB-O)\nE\nndometrial (AUB-E)\nI\natrogenic (AUB-I)\nN\not yet classified (AUB-N)",
          "tables": []
        },
        "Diagnosis": {
          "text": "Common etiologies by age:\nAge 12-18: most commonly immature hypothalamic-pituitary-ovarian axis, also consider bleeding dyscrasia\nAge 19-39: most commonly structural lesion (fibroid, polyp) or PCOS\nAge 40+: most commonly endometrial atrophy, also consider malignancy especially in post-menopausal\n[2]\nHemodynamically stable patient in ED must rule-out:\nPregnancy\nTrauma\nBleeding dyscrasia\nInfection\nRetained\nvaginal foreign body\nIf work up negative, can refer for further outpatient work up",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Coags",
          "url": "https://wikem.org/wiki/Coags"
        },
        {
          "text": "TSH",
          "url": "https://wikem.org/wiki/TSH"
        },
        {
          "text": "C. trachomatis",
          "url": "https://wikem.org/wiki/C._trachomatis"
        },
        {
          "text": "N. gonorrhoeae",
          "url": "https://wikem.org/wiki/N._gonorrhoeae"
        },
        {
          "text": "pelvic ultrasound",
          "url": "https://wikem.org/wiki/Pelvic_ultrasound"
        },
        {
          "text": "Coagulopathy",
          "url": "https://wikem.org/wiki/Coagulopathy"
        },
        {
          "text": "Pregnancy",
          "url": "https://wikem.org/wiki/Pregnancy"
        },
        {
          "text": "Trauma",
          "url": "https://wikem.org/wiki/Trauma"
        },
        {
          "text": "Bleeding dyscrasia",
          "url": "https://wikem.org/wiki/Coagulopathy"
        },
        {
          "text": "Infection",
          "url": "https://wikem.org/wiki/Infection"
        },
        {
          "text": "vaginal foreign body",
          "url": "https://wikem.org/wiki/Vaginal_foreign_body"
        }
      ]
    },
    "PALM-COEIN_Classification_of_Vaginal_Bleeding": {
      "text": "PALM\n: structural causes\nP\nolyp (AUB-P)\nA\ndenomyosis (AUB-A)\nL\neiomyoma (AUB-L)\nM\nalignancy and hyperplasia (AUB-M)\nCOEIN\n: nonstructural causes\nC\noagulopathy\n(AUB-C)\nO\nvulatory dysfunction (AUB-O)\nE\nndometrial (AUB-E)\nI\natrogenic (AUB-I)\nN\not yet classified (AUB-N)",
      "subsections": {
        "Diagnosis": {
          "text": "Common etiologies by age:\nAge 12-18: most commonly immature hypothalamic-pituitary-ovarian axis, also consider bleeding dyscrasia\nAge 19-39: most commonly structural lesion (fibroid, polyp) or PCOS\nAge 40+: most commonly endometrial atrophy, also consider malignancy especially in post-menopausal\n[2]\nHemodynamically stable patient in ED must rule-out:\nPregnancy\nTrauma\nBleeding dyscrasia\nInfection\nRetained\nvaginal foreign body\nIf work up negative, can refer for further outpatient work up",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Coagulopathy",
          "url": "https://wikem.org/wiki/Coagulopathy"
        },
        {
          "text": "Pregnancy",
          "url": "https://wikem.org/wiki/Pregnancy"
        },
        {
          "text": "Trauma",
          "url": "https://wikem.org/wiki/Trauma"
        },
        {
          "text": "Bleeding dyscrasia",
          "url": "https://wikem.org/wiki/Coagulopathy"
        },
        {
          "text": "Infection",
          "url": "https://wikem.org/wiki/Infection"
        },
        {
          "text": "vaginal foreign body",
          "url": "https://wikem.org/wiki/Vaginal_foreign_body"
        }
      ]
    },
    "Diagnosis": {
      "text": "Common etiologies by age:\nAge 12-18: most commonly immature hypothalamic-pituitary-ovarian axis, also consider bleeding dyscrasia\nAge 19-39: most commonly structural lesion (fibroid, polyp) or PCOS\nAge 40+: most commonly endometrial atrophy, also consider malignancy especially in post-menopausal\n[2]\nHemodynamically stable patient in ED must rule-out:\nPregnancy\nTrauma\nBleeding dyscrasia\nInfection\nRetained\nvaginal foreign body\nIf work up negative, can refer for further outpatient work up",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Pregnancy",
          "url": "https://wikem.org/wiki/Pregnancy"
        },
        {
          "text": "Trauma",
          "url": "https://wikem.org/wiki/Trauma"
        },
        {
          "text": "Bleeding dyscrasia",
          "url": "https://wikem.org/wiki/Coagulopathy"
        },
        {
          "text": "Infection",
          "url": "https://wikem.org/wiki/Infection"
        },
        {
          "text": "vaginal foreign body",
          "url": "https://wikem.org/wiki/Vaginal_foreign_body"
        }
      ]
    },
    "Management": {
      "text": "If you are concerned for malignancy, hormonal therapy should be avoided unless discussed with OBGYN, as these medications may interfere with possible biopsy results.",
      "subsections": {
        "Mild_Bleeding": {
          "text": "Iron supplementation\n324mg ferrous sulfate tablet PO TID (each tab contains 65mg of elemental iron)\nNSAIDs\ne.g.\nibuprofen\n400 mg PO q6h, or\nnaproxen\n500 mg PO BID\nFor cramping pain and can decreases intra-uterine bleeding. Reduces endometrial prostaglandin levels and promotes vasoconstriction in the uterus",
          "tables": []
        },
        "Moderate_continued_bleeding": {
          "text": "Patients may benefit from initiation of short or long-term birth control for acute cessation.\nCombined OCPs\nAny combined OCP that contains\n35 ug of ethinyl estradiol TID for 7 days\n. (e.g., Ortho-Novum 1/35®)\n[3]\n88% success, median time 3 days\n[4]\nContraindications\nCigarette smoking if older than 34 years\nHypertension\nHistory of\nVTE\nCerebrovascular disease\nCAD or valvular disease\nHistory of breast cancer\nDiabetes\nwith vascular involvement\nSurgery with immobilization\nLiver\ncirrhosis\nOther pro-coagulative conditions (e.g.\nLupus\n,\nFactor V Leiden\n)\nMedroxyprogesterone\n20 mg PO TID for 7 days\n[3]\n76% success, median time 3 days\nAlternative, not officially endorsed by ACOG: 150mg IM x 1 then 20 mg PO TID x 3 days\nIn a trial of 48 patients all had cessation in 5 days.\n[5]\nContraindications\nHistory of\nVTE\nHistory of arterial thromboembolic events\nHistory of breast cancer\nLiver disease",
          "tables": []
        },
        "Life_Threatening": {
          "text": "Establish large bore IV access\nPrepare for emergent\nblood transfusion\nuncrossmatched\nO-negative blood\nif typed blood is not available.\nIt is possible to temporize bleeding w/ intravaginal packing with kerlix soaked in with thrombin\nIf bleeding is due to a traumatic cause emergent surgical repair is necessary\nTranexamic acid\n[6]\nCoordinate with OBGYN prior to administration due to the increased thrombotic risk\nAcutely 1.0-1.3 grams IV\nThen 1-1.3 g TID PO for 5 days",
          "tables": []
        },
        "Pharmacologic_Treatment_Regimens_For_Acute_Abnormal_Uterine_Bleeding[7]": {
          "text": "",
          "tables": [
            [
              {
                "Drug": "Conjugated equine estrogen",
                "Suggested Dose": "25 mg IV every 4-6 h until bleeding stops, up to 24 h",
                "Contraindications": "Active or past thromboembolic disease, breast cancer, or liver disease"
              },
              {
                "Drug": "Combination oral contraceptive pills",
                "Suggested Dose": "1 pill TID PO for 7 days or 1 pill bid PO for 5 days, then 1 pill daily until pack is finished",
                "Contraindications": "> 35 y who smoke, history of DVT or PE, breast cancer, liver disease, known thromboembolic disorders, pregnancy, ischemic heart disease, cerebrovascular disease, or uncontrolled hypertension"
              },
              {
                "Drug": "Progestin-only oral contraceptive pills (medroxyprogesteroneacetate)",
                "Suggested Dose": "20 mg TID PO for 7 days or 10 mg daily PO for 10 days",
                "Contraindications": "Active or past DVT or PE, liver disease, or breast cancer"
              },
              {
                "Drug": "NSAIDs:Ibuprofen",
                "Suggested Dose": "200-400 mg 3-4 times/day PO for 5 days",
                "Contraindications": "Advanced renal disease"
              },
              {
                "Drug": "Antifibrinolytic agents (tranexamic acid)",
                "Suggested Dose": "1.3 g TID PO for up to 5 days",
                "Contraindications": "Active intravascular clotting or subarachnoid hemorrhage"
              }
            ]
          ]
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Iron supplementation",
          "url": "https://wikem.org/wiki/Iron_supplementation"
        },
        {
          "text": "NSAIDs",
          "url": "https://wikem.org/wiki/NSAIDs"
        },
        {
          "text": "ibuprofen",
          "url": "https://wikem.org/wiki/Ibuprofen"
        },
        {
          "text": "naproxen",
          "url": "https://wikem.org/wiki/Naproxen"
        },
        {
          "text": "Hypertension",
          "url": "https://wikem.org/wiki/Hypertension"
        },
        {
          "text": "VTE",
          "url": "https://wikem.org/wiki/VTE"
        },
        {
          "text": "Diabetes",
          "url": "https://wikem.org/wiki/Diabetes"
        },
        {
          "text": "cirrhosis",
          "url": "https://wikem.org/wiki/Cirrhosis"
        },
        {
          "text": "Lupus",
          "url": "https://wikem.org/wiki/Lupus"
        },
        {
          "text": "Factor V Leiden",
          "url": "https://wikem.org/wiki/Factor_V_Leiden"
        },
        {
          "text": "Medroxyprogesterone",
          "url": "https://wikem.org/wiki/Medroxyprogesterone"
        },
        {
          "text": "VTE",
          "url": "https://wikem.org/wiki/VTE"
        },
        {
          "text": "blood transfusion",
          "url": "https://wikem.org/wiki/Blood_transfusion"
        },
        {
          "text": "Tranexamic acid",
          "url": "https://wikem.org/wiki/Tranexamic_acid"
        }
      ]
    },
    "Mild_Bleeding": {
      "text": "Iron supplementation\n324mg ferrous sulfate tablet PO TID (each tab contains 65mg of elemental iron)\nNSAIDs\ne.g.\nibuprofen\n400 mg PO q6h, or\nnaproxen\n500 mg PO BID\nFor cramping pain and can decreases intra-uterine bleeding. Reduces endometrial prostaglandin levels and promotes vasoconstriction in the uterus",
      "subsections": {
        "Moderate_continued_bleeding": {
          "text": "Patients may benefit from initiation of short or long-term birth control for acute cessation.\nCombined OCPs\nAny combined OCP that contains\n35 ug of ethinyl estradiol TID for 7 days\n. (e.g., Ortho-Novum 1/35®)\n[3]\n88% success, median time 3 days\n[4]\nContraindications\nCigarette smoking if older than 34 years\nHypertension\nHistory of\nVTE\nCerebrovascular disease\nCAD or valvular disease\nHistory of breast cancer\nDiabetes\nwith vascular involvement\nSurgery with immobilization\nLiver\ncirrhosis\nOther pro-coagulative conditions (e.g.\nLupus\n,\nFactor V Leiden\n)\nMedroxyprogesterone\n20 mg PO TID for 7 days\n[3]\n76% success, median time 3 days\nAlternative, not officially endorsed by ACOG: 150mg IM x 1 then 20 mg PO TID x 3 days\nIn a trial of 48 patients all had cessation in 5 days.\n[5]\nContraindications\nHistory of\nVTE\nHistory of arterial thromboembolic events\nHistory of breast cancer\nLiver disease",
          "tables": []
        },
        "Life_Threatening": {
          "text": "Establish large bore IV access\nPrepare for emergent\nblood transfusion\nuncrossmatched\nO-negative blood\nif typed blood is not available.\nIt is possible to temporize bleeding w/ intravaginal packing with kerlix soaked in with thrombin\nIf bleeding is due to a traumatic cause emergent surgical repair is necessary\nTranexamic acid\n[6]\nCoordinate with OBGYN prior to administration due to the increased thrombotic risk\nAcutely 1.0-1.3 grams IV\nThen 1-1.3 g TID PO for 5 days",
          "tables": []
        },
        "Pharmacologic_Treatment_Regimens_For_Acute_Abnormal_Uterine_Bleeding[7]": {
          "text": "",
          "tables": [
            [
              {
                "Drug": "Conjugated equine estrogen",
                "Suggested Dose": "25 mg IV every 4-6 h until bleeding stops, up to 24 h",
                "Contraindications": "Active or past thromboembolic disease, breast cancer, or liver disease"
              },
              {
                "Drug": "Combination oral contraceptive pills",
                "Suggested Dose": "1 pill TID PO for 7 days or 1 pill bid PO for 5 days, then 1 pill daily until pack is finished",
                "Contraindications": "> 35 y who smoke, history of DVT or PE, breast cancer, liver disease, known thromboembolic disorders, pregnancy, ischemic heart disease, cerebrovascular disease, or uncontrolled hypertension"
              },
              {
                "Drug": "Progestin-only oral contraceptive pills (medroxyprogesteroneacetate)",
                "Suggested Dose": "20 mg TID PO for 7 days or 10 mg daily PO for 10 days",
                "Contraindications": "Active or past DVT or PE, liver disease, or breast cancer"
              },
              {
                "Drug": "NSAIDs:Ibuprofen",
                "Suggested Dose": "200-400 mg 3-4 times/day PO for 5 days",
                "Contraindications": "Advanced renal disease"
              },
              {
                "Drug": "Antifibrinolytic agents (tranexamic acid)",
                "Suggested Dose": "1.3 g TID PO for up to 5 days",
                "Contraindications": "Active intravascular clotting or subarachnoid hemorrhage"
              }
            ]
          ]
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Iron supplementation",
          "url": "https://wikem.org/wiki/Iron_supplementation"
        },
        {
          "text": "NSAIDs",
          "url": "https://wikem.org/wiki/NSAIDs"
        },
        {
          "text": "ibuprofen",
          "url": "https://wikem.org/wiki/Ibuprofen"
        },
        {
          "text": "naproxen",
          "url": "https://wikem.org/wiki/Naproxen"
        },
        {
          "text": "Hypertension",
          "url": "https://wikem.org/wiki/Hypertension"
        },
        {
          "text": "VTE",
          "url": "https://wikem.org/wiki/VTE"
        },
        {
          "text": "Diabetes",
          "url": "https://wikem.org/wiki/Diabetes"
        },
        {
          "text": "cirrhosis",
          "url": "https://wikem.org/wiki/Cirrhosis"
        },
        {
          "text": "Lupus",
          "url": "https://wikem.org/wiki/Lupus"
        },
        {
          "text": "Factor V Leiden",
          "url": "https://wikem.org/wiki/Factor_V_Leiden"
        },
        {
          "text": "Medroxyprogesterone",
          "url": "https://wikem.org/wiki/Medroxyprogesterone"
        },
        {
          "text": "VTE",
          "url": "https://wikem.org/wiki/VTE"
        },
        {
          "text": "blood transfusion",
          "url": "https://wikem.org/wiki/Blood_transfusion"
        },
        {
          "text": "Tranexamic acid",
          "url": "https://wikem.org/wiki/Tranexamic_acid"
        }
      ]
    },
    "Moderate_continued_bleeding": {
      "text": "Patients may benefit from initiation of short or long-term birth control for acute cessation.\nCombined OCPs\nAny combined OCP that contains\n35 ug of ethinyl estradiol TID for 7 days\n. (e.g., Ortho-Novum 1/35®)\n[3]\n88% success, median time 3 days\n[4]\nContraindications\nCigarette smoking if older than 34 years\nHypertension\nHistory of\nVTE\nCerebrovascular disease\nCAD or valvular disease\nHistory of breast cancer\nDiabetes\nwith vascular involvement\nSurgery with immobilization\nLiver\ncirrhosis\nOther pro-coagulative conditions (e.g.\nLupus\n,\nFactor V Leiden\n)\nMedroxyprogesterone\n20 mg PO TID for 7 days\n[3]\n76% success, median time 3 days\nAlternative, not officially endorsed by ACOG: 150mg IM x 1 then 20 mg PO TID x 3 days\nIn a trial of 48 patients all had cessation in 5 days.\n[5]\nContraindications\nHistory of\nVTE\nHistory of arterial thromboembolic events\nHistory of breast cancer\nLiver disease",
      "subsections": {
        "Life_Threatening": {
          "text": "Establish large bore IV access\nPrepare for emergent\nblood transfusion\nuncrossmatched\nO-negative blood\nif typed blood is not available.\nIt is possible to temporize bleeding w/ intravaginal packing with kerlix soaked in with thrombin\nIf bleeding is due to a traumatic cause emergent surgical repair is necessary\nTranexamic acid\n[6]\nCoordinate with OBGYN prior to administration due to the increased thrombotic risk\nAcutely 1.0-1.3 grams IV\nThen 1-1.3 g TID PO for 5 days",
          "tables": []
        },
        "Pharmacologic_Treatment_Regimens_For_Acute_Abnormal_Uterine_Bleeding[7]": {
          "text": "",
          "tables": [
            [
              {
                "Drug": "Conjugated equine estrogen",
                "Suggested Dose": "25 mg IV every 4-6 h until bleeding stops, up to 24 h",
                "Contraindications": "Active or past thromboembolic disease, breast cancer, or liver disease"
              },
              {
                "Drug": "Combination oral contraceptive pills",
                "Suggested Dose": "1 pill TID PO for 7 days or 1 pill bid PO for 5 days, then 1 pill daily until pack is finished",
                "Contraindications": "> 35 y who smoke, history of DVT or PE, breast cancer, liver disease, known thromboembolic disorders, pregnancy, ischemic heart disease, cerebrovascular disease, or uncontrolled hypertension"
              },
              {
                "Drug": "Progestin-only oral contraceptive pills (medroxyprogesteroneacetate)",
                "Suggested Dose": "20 mg TID PO for 7 days or 10 mg daily PO for 10 days",
                "Contraindications": "Active or past DVT or PE, liver disease, or breast cancer"
              },
              {
                "Drug": "NSAIDs:Ibuprofen",
                "Suggested Dose": "200-400 mg 3-4 times/day PO for 5 days",
                "Contraindications": "Advanced renal disease"
              },
              {
                "Drug": "Antifibrinolytic agents (tranexamic acid)",
                "Suggested Dose": "1.3 g TID PO for up to 5 days",
                "Contraindications": "Active intravascular clotting or subarachnoid hemorrhage"
              }
            ]
          ]
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Hypertension",
          "url": "https://wikem.org/wiki/Hypertension"
        },
        {
          "text": "VTE",
          "url": "https://wikem.org/wiki/VTE"
        },
        {
          "text": "Diabetes",
          "url": "https://wikem.org/wiki/Diabetes"
        },
        {
          "text": "cirrhosis",
          "url": "https://wikem.org/wiki/Cirrhosis"
        },
        {
          "text": "Lupus",
          "url": "https://wikem.org/wiki/Lupus"
        },
        {
          "text": "Factor V Leiden",
          "url": "https://wikem.org/wiki/Factor_V_Leiden"
        },
        {
          "text": "Medroxyprogesterone",
          "url": "https://wikem.org/wiki/Medroxyprogesterone"
        },
        {
          "text": "VTE",
          "url": "https://wikem.org/wiki/VTE"
        },
        {
          "text": "blood transfusion",
          "url": "https://wikem.org/wiki/Blood_transfusion"
        },
        {
          "text": "Tranexamic acid",
          "url": "https://wikem.org/wiki/Tranexamic_acid"
        }
      ]
    },
    "Life_Threatening": {
      "text": "Establish large bore IV access\nPrepare for emergent\nblood transfusion\nuncrossmatched\nO-negative blood\nif typed blood is not available.\nIt is possible to temporize bleeding w/ intravaginal packing with kerlix soaked in with thrombin\nIf bleeding is due to a traumatic cause emergent surgical repair is necessary\nTranexamic acid\n[6]\nCoordinate with OBGYN prior to administration due to the increased thrombotic risk\nAcutely 1.0-1.3 grams IV\nThen 1-1.3 g TID PO for 5 days",
      "subsections": {
        "Pharmacologic_Treatment_Regimens_For_Acute_Abnormal_Uterine_Bleeding[7]": {
          "text": "",
          "tables": [
            [
              {
                "Drug": "Conjugated equine estrogen",
                "Suggested Dose": "25 mg IV every 4-6 h until bleeding stops, up to 24 h",
                "Contraindications": "Active or past thromboembolic disease, breast cancer, or liver disease"
              },
              {
                "Drug": "Combination oral contraceptive pills",
                "Suggested Dose": "1 pill TID PO for 7 days or 1 pill bid PO for 5 days, then 1 pill daily until pack is finished",
                "Contraindications": "> 35 y who smoke, history of DVT or PE, breast cancer, liver disease, known thromboembolic disorders, pregnancy, ischemic heart disease, cerebrovascular disease, or uncontrolled hypertension"
              },
              {
                "Drug": "Progestin-only oral contraceptive pills (medroxyprogesteroneacetate)",
                "Suggested Dose": "20 mg TID PO for 7 days or 10 mg daily PO for 10 days",
                "Contraindications": "Active or past DVT or PE, liver disease, or breast cancer"
              },
              {
                "Drug": "NSAIDs:Ibuprofen",
                "Suggested Dose": "200-400 mg 3-4 times/day PO for 5 days",
                "Contraindications": "Advanced renal disease"
              },
              {
                "Drug": "Antifibrinolytic agents (tranexamic acid)",
                "Suggested Dose": "1.3 g TID PO for up to 5 days",
                "Contraindications": "Active intravascular clotting or subarachnoid hemorrhage"
              }
            ]
          ]
        }
      },
      "tables": [],
      "links": [
        {
          "text": "blood transfusion",
          "url": "https://wikem.org/wiki/Blood_transfusion"
        },
        {
          "text": "Tranexamic acid",
          "url": "https://wikem.org/wiki/Tranexamic_acid"
        }
      ]
    },
    "Disposition": {
      "text": "Most can be discharged home with OB/GYN follow-up\nFor severe anemia or persistent exceedingly heavy flow, consider admission and/or discussion with OB/GYN\nSurgical options, when medical management fails, include hysterectomy, endometrial baloon tamponade, dilatation and curettage, uterine artery embolization",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "See_Also": {
      "text": "",
      "subsections": {
        "Vaginal_bleeding_(main)": {
          "text": "Non-pregnant vaginal bleeding\nPrepubertal vaginal bleeding\nPregnant\nVaginal bleeding in pregnancy (less than 20wks)\nVaginal bleeding in pregnancy (greater than 20wks)\nPostpartum hemorrhage",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Non-pregnant vaginal bleeding",
          "url": "https://wikem.org/wiki/Non-pregnant_vaginal_bleeding"
        },
        {
          "text": "Prepubertal vaginal bleeding",
          "url": "https://wikem.org/wiki/Prepubertal_vaginal_bleeding"
        },
        {
          "text": "Pregnant",
          "url": "https://wikem.org/wiki/Pregnancy_(main)"
        },
        {
          "text": "Vaginal bleeding in pregnancy (less than 20wks)",
          "url": "https://wikem.org/wiki/Vaginal_bleeding_in_pregnancy_(less_than_20wks)"
        },
        {
          "text": "Vaginal bleeding in pregnancy (greater than 20wks)",
          "url": "https://wikem.org/wiki/Vaginal_bleeding_in_pregnancy_(greater_than_20wks)"
        },
        {
          "text": "Postpartum hemorrhage",
          "url": "https://wikem.org/wiki/Postpartum_hemorrhage"
        }
      ]
    },
    "See_Also_2": {
      "text": "Vaginal Bleeding (Main)",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Vaginal Bleeding (Main)",
          "url": "https://wikem.org/wiki/Vaginal_Bleeding_(Main)"
        }
      ]
    }
  }
}